The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Cost efficiency and budget-neutral expanded access to antineoplastic therapy from cost-savings derived from conversion to biosimilar pegfilgrastim-cbqv for the prophylaxis of chemotherapy-induced (febrile) neutropenia (CIN/FN):Simulation modeling in metastatic pancreatic cancer.

Ali  McBride

Consulting or Advisory Role - Bristol-Myers Squibb; Coherus BioSciences; MorphoSys; Pfizer; Sandoz

Speakers' Bureau - Coherus BioSciences; Merck

Karen  MacDonald

Consulting or Advisory Role - Celgene (Inst); Janssen (Inst); MorphoSys (Inst); Novartis (Inst); Rockwell Medical (Inst); Sandoz (Inst); TERUMO (Inst)

Research Funding - Coherus BioSciences (Inst)

Ivo  Abraham

Stock and Other Ownership Interests  - Matrix45; Matrix45 (I)